Patient registry launches to track myasthenia gravis care
The first patient has been enrolled in a myasthenia gravis (MG) registry to collect clinical information from real-world settings…
Articles by Margarida Maia, PhD
Scholarship success stories inspire new round of MG applications
Fifteen college or trade school scholarships are now available for people with myasthenia gravis (MG) and their immediate family…
Immune cell types may predict recovery in MG, study finds
People who recover from myasthenia gravis (MG) after long-term treatment have higher numbers of certain subsets of monocytes —…
NfL protein in blood may help track myasthenia gravis severity: Study
People with myasthenia gravis (MG) have higher levels of a protein called neurofilament light chain (NfL) in their blood,…
FDA grants orphan drug designation to CNP-106 for gMG
The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to CNP-106, an experimental treatment that…
Vyvgart eases gMG impact on daily living in seronegative adults in trial
Treatment with Vyvgart (efgartigimod alfa-fcab) helped reduce the impact of generalized myasthenia gravis (gMG) on activities of daily…
Study IDs possible ‘off switch’ for overactive immune response in MG
Tapping into PD-1/PD-L1 immune checkpoint proteins — which serve as a kind of natural off switch for an overactive immune…
Blinatumomab helps 2 women with resistant MG: Case report
A case report from Germany showed that two women with severe, treatment-resistant myasthenia gravis (MG) responded well to blinatumomab,…
Azathioprine eases MG symptoms, but does not extend survival: Study
Azathioprine did not outperform standard treatment in helping adults with myasthenia gravis (MG) live longer, and while older age…
Povetacicept reduces disease activity in MG mouse model
Povetacicept, a treatment for autoimmune diseases in the pipeline of Vertex Pharmaceuticals, reduced disease activity in a study with…